Farmakokinetik for atazanavir er evalueret hos raske, voksne frivillige og hos HIV- inficerede patienter; der er observeret væsentlige forskelle mellem de to grupper.
The pharmacokinetics of atazanavir were evaluated in healthy adult volunteers and in HIV-infected patients; significant differences were observed between the two groups.